Skip to main content

Articles

Page 8 of 76

  1. The 5 year survival rate after diagnosis of pancreatic cancer (PANC) is less than 5%, and it is one of the malignant tumors with the worst prognosis. Identification of novel oncogenes involved in the occurrenc...

    Authors: Hui Wu, Anshu Li, Qichang Zheng, Jingyang Gu and Wei Zhou
    Citation: Cancer Cell International 2023 23:130
  2. The gefitinib resistance mechanism in non-small cell lung cancer (NSCLC) remains unclear, albeit exosomal circular RNA (circRNA) is known to possibly play a vital role in it.

    Authors: Si-Liang Wei, Jing-Jing Ye, Li Sun, Lei Hu, Yuan-Yuan Wei, Da-Wei Zhang, Meng-Meng Xu and Guang-He Fei
    Citation: Cancer Cell International 2023 23:129
  3. Myelodysplastic syndrome (MDS) is a clonal bone marrow disorder defined by cytopenia and is associated with an increased risk of transformation to acute myeloid leukemia (AML). The outcome of MDS is poor, so a...

    Authors: Seiichi Okabe, Yuko Tanaka, Mitsuru Moriyama and Akihiko Gotoh
    Citation: Cancer Cell International 2023 23:128
  4. N6-methyladenosine (m6A), one of the most common RNA methylation modifications, has emerged in recent years as a new layer of the regulatory mechanism controlling gene expression in eukaryotes. As a reversible ep...

    Authors: Nan Zhang, Yifei Sun, Zongqin Mei, Zuoshun He and Shiyan Gu
    Citation: Cancer Cell International 2023 23:127
  5. Papillary renal cell carcinoma (pRCC) is a highly metastatic genitourinary cancer and is generally irresponsive to common treatments used for the more prevalent clear-cell (ccRCC) subtype. The goal of this stu...

    Authors: Priyanka F. Karmokar and Nader H. Moniri
    Citation: Cancer Cell International 2023 23:126
  6. Uterine corpus endometrial carcinoma (UCEC) is a gynecological malignant tumor with high incidence and poor prognosis. Although immunotherapy has brought significant survival benefits to advanced UCEC patients...

    Authors: Ganghua Zhang, Zhijing Yin, Jianing Fang, Anshan Wu, Guanjun Chen and Ke Cao
    Citation: Cancer Cell International 2023 23:124
  7. PRKCG encodes PKC γ, which is categorized under the classical protein kinase C family. No studies have specifically established the relationship between PRKCG nsSNPs with structural and functional variations i...

    Authors: Fizzah Abid, Khushbukhat Khan, Yasmin Badshah, Naeem Mahmood Ashraf, Maria Shabbir, Arslan Hamid, Tayyaba Afsar, Ali Almajwal and Suhail Razak
    Citation: Cancer Cell International 2023 23:123
  8. Skin cutaneous melanoma (SKCM) is the most threatening type of skin cancer. Approximately 55,000 people lose their lives every year due to SKCM, illustrating that it seriously threatens human life and health. ...

    Authors: Song He, Yu Ding, Zhonghao Ji, Bao Yuan, Jian Chen and Wenzhi Ren
    Citation: Cancer Cell International 2023 23:122
  9. Breast cancer is the world’s most prevalent cancer among women. Microorganisms have been the richest source of antibiotics as well as anticancer drugs. Moricin peptides have shown antibacterial properties; how...

    Authors: Imran Ahmad, Saurabh Pal, Ranjana Singh, Khursheed Ahmad, Nilanjan Dey, Aditi Srivastava, Rumana Ahmad, Muath Suliman, Mohammad Y. Alshahrani, Md. Abul Barkat and Sahabjada Siddiqui
    Citation: Cancer Cell International 2023 23:121

    The Correction to this article has been published in Cancer Cell International 2023 23:139

  10. Establishing appropriate preclinical models is essential for cancer research. Evidence suggests that cancer is a highly heterogeneous disease. This follows the growing use of cancer models in cancer research t...

    Authors: Mingtang Zeng, Zijing Ruan, Jiaxi Tang, Maozhu Liu, Chengji Hu, Ping Fan and Xinhua Dai
    Citation: Cancer Cell International 2023 23:120
  11. Complexity and heterogeneity of the tumor niche are closely associated with the failure of therapeutic protocols. Unfortunately, most data have been obtained from conventional 2D culture systems which are not ...

    Authors: Maryam Taghavi Narmi, Hanieh Mohajjel Shoja, Sanya Haiaty, Mahdi Mahdipour and Reza Rahbarghazi
    Citation: Cancer Cell International 2023 23:118
  12. As a core member of the FA complex, in the Fanconi anemia pathway, FAAP24 plays an important role in DNA damage repair. However, the association between FAAP24 and patient prognosis in AML and immune infiltration...

    Authors: Xiebing Bao, Jingyun Chi, Yiwei Zhu, Minfeng Yang, Jiahui Du, Zaixiang Tang, Xiaogang Xu, Genxiang Mao, Zhibing Wu, Jun Chen, Jingsheng Hua, Ting Xu and Song-Bai Liu
    Citation: Cancer Cell International 2023 23:117
  13. Cytotoxic anticancer drugs widely used in cancer chemotherapy have some limitations, such as the development of side effects and drug resistance. Furthermore, monotherapy is often less effective against hetero...

    Authors: Kou Nishikubo, Ryuichi Ohgaki, Xingming Liu, Hiroki Okanishi, Minhui Xu, Hitoshi Endou and Yoshikatsu Kanai
    Citation: Cancer Cell International 2023 23:116
  14. Despite the success of cancer therapy, it has encountered a major obstacle due to the complicated nature of cancer, namely resistance. The recurrence and metastasis of cancer occur when anti-cancer therapeutic...

    Authors: Aysooda Hosseinzadeh, Faezeh Poursoleiman, Akram Naghdipour Biregani and Ahmad Esmailzadeh
    Citation: Cancer Cell International 2023 23:114
  15. C-type lectin domain family 1 member B (CLEC1B, encoding the CLEC-2 protein), a member of the C-type lectin superfamily, is a type II transmembrane receptor involved in platelet activation, angiogenesis, and i...

    Authors: Qiangan Jing, Chen Yuan, Chaoting Zhou, Weidong Jin, Aiwei Wang, Yanfang Wu, Wenzhong Shang, Guibing Zhang, Xia Ke, Jing Du, Yanchun Li and Fangchun Shao
    Citation: Cancer Cell International 2023 23:113
  16. Oral squamous cell carcinoma (OSCC) is the predominant histological type of the head and neck squamous cell carcinoma (HNSCC). By comparing the differentially expressed genes (DEGs) in OSCC-TCGA patients with ...

    Authors: Wei-Chen Yen, Kai-Ping Chang, Cheng-Yi Chen, Yenlin Huang, Ting-Wen Chen, Hsing-Wen Cheng, Jui-Shan Yi, Chun-Chia Cheng, Chih-Ching Wu and Chun-I Wang
    Citation: Cancer Cell International 2023 23:112
  17. Glioblastoma is the most common primary central nervous system tumor in adults. Angiotensin II receptor blockers (ARBs) are broadly applied to treat hypertension. Moreover, research has revealed that ARBs have...

    Authors: Yung-Lung Chang, Chung-Hsing Chou, Yao-Feng Li, Li-Chun Huang, Ying Kao, Dueng-Yuan Hueng and Chia-Kuang Tsai
    Citation: Cancer Cell International 2023 23:111
  18. Currently, tumor-treating field (TTField) therapy utilizes a single “optimal” frequency of electric fields to achieve maximal cell death in a targeted population of cells. However, because of differences in ce...

    Authors: Austin R. Smothers, Jason R. Henderson, John J. O’Connell, Jonathan M. Stenbeck, Delphine Dean and Brian W. Booth
    Citation: Cancer Cell International 2023 23:110
  19. Malignant transformation from hepatic fibrosis to carcinogenesis may be a therapeutic target for hepatocellular carcinoma (HCC). The aim of this study was to evaluate anti-cancer efficacy of Pien-Tze-Huang (PZ...

    Authors: Xiangying Yan, Yudong Liu, Congchong Li, Xia Mao, Tengteng Xu, Zhixing Hu, Chu Zhang, Na Lin, Ya Lin and Yanqiong Zhang
    Citation: Cancer Cell International 2023 23:109
  20. Although autophagy is an important mediator of metformin antitumor activity, the role of metformin in the crosstalk between autophagy and apoptosis remains unclear. The aim was to confirm the anticancer effect...

    Authors: Da Eun Lee, Geun Yong Lee, Hae Min Lee, Soo Young Choi, Su Jin Lee and Oh-Shin Kwon
    Citation: Cancer Cell International 2023 23:108
  21. Radiotherapy is one of the effective methods for treatment of breast cancer; however, controversies still exist with respect to radiotherapy for patients with TNBC. Here, we intend to explore the mechanism by ...

    Authors: Zhengzheng Zhang, Zhiyan Yao, Zimeng Zhang, Ling Cui, Ling Zhang, Gang Qiu, Xiaotian Song and Shuxia Song
    Citation: Cancer Cell International 2023 23:107
  22. BCR::ABL1 fusion has significant prognostic value and is screened for chronic myeloid leukemia (CML) disease monitoring as a part of routine molecular testing. To overcome the limitations of the current standard ...

    Authors: Hyeonah Lee, Jieun Seo, Saeam Shin, Seung-Tae Lee and Jong Rak Choi
    Citation: Cancer Cell International 2023 23:106
  23. Copper homeostasis is associated with malignant biological behavior in various tumors. The excessive accumulation of copper can induce tumor death, which is named cuproptosis, and it is also closely related to...

    Authors: Tao Yan, He Yang, Yun Meng, Huadong Li, Qing Jiang, Junsi Liu, Caixia Xu, Yanpeng Xue, Jiayi Xu, Yan Song, Xiaojie Chu, Lijuan Wang, Xin Chen and Fengyuan Che
    Citation: Cancer Cell International 2023 23:105
  24. Chemotherapy and surgery have been the mainstays of epithelial ovarian cancer (EOC) treatment so far. Cellular immunotherapies such as CAR T cell therapy have recently given hope of a cure for solid tumors lik...

    Authors: Behnia Akbari, Tahereh Soltantoyeh, Zahra Shahosseini, Fariba Yarandi, Jamshid Hadjati and Hamid Reza Mirzaei
    Citation: Cancer Cell International 2023 23:104
  25. Oxaliplatin-based chemotherapy is the first-line treatment for colorectal cancer (CRC). Long noncoding RNAs (lncRNAs) have been implicated in chemotherapy sensitivity. This study aimed to identify lncRNAs rela...

    Authors: Qing-nan Zhou, Rong-e Lei, Yun-xiao Liang, Si-qi Li, Xian-wen Guo and Bang-li Hu
    Citation: Cancer Cell International 2023 23:103
  26. Enhanced glucose metabolism is a feature of most tumors, but downstream functional effects of aberrant glucose flux are difficult to mechanistically determine. Metabolic diseases including obesity and diabetes...

    Authors: Saheed A. Ayodeji, Bin Bao, Emily A. Teslow, Lisa A. Polin, Greg Dyson, Aliccia Bollig-Fischer and Charlie Fehl
    Citation: Cancer Cell International 2023 23:102
  27. Oral cancers are among the common head and neck malignancies. Different anticancer therapy modalities such as chemotherapy, immunotherapy, radiation therapy, and also targeted molecular therapy may be prescrib...

    Authors: Hendrik Setia Budi and Bagher Farhood
    Citation: Cancer Cell International 2023 23:101
  28. Neurofibromatosis type 2 (NF2) is a genetic condition marked by the development of multiple benign tumors in the nervous system. The most common tumors associated with NF2 are bilateral vestibular schwannoma, ...

    Authors: Mohammad Amin Ghalavand, Alimohamad Asghari, Mohammad Farhadi, Farzad Taghizadeh-Hesary, Masoud Garshasbi and Masoumeh Falah
    Citation: Cancer Cell International 2023 23:99
  29. Glioblastoma (GBM) is an aggressive type of cancer that originates in the cells called astrocytes, which support the functioning of nerve cells. It can develop in either the brain or the spinal cord and is als...

    Authors: Arianaz Hosseini, Hami Ashraf, Fatemeh Rahimi, Iraj Alipourfard, Vahid Alivirdiloo, Behnam Hashemi, Yalda Yazdani, Farhood Ghazi, Majid Eslami, Mahdieh Ameri Shah Reza and Mehdi Dadashpour
    Citation: Cancer Cell International 2023 23:98
  30. Development of precision medicine requires the identification of easily detectable and druggable biomarkers. Despite recent targeted drug approvals, prognosis of acute myeloid leukemia (AML) patients needs to ...

    Authors: Laia Cuesta-Casanovas, Jennifer Delgado-Martínez, Josep M. Cornet-Masana, José M. Carbó, Antònia Banús-Mulet, Francesca Guijarro, Jordi Esteve and Ruth M. Risueño
    Citation: Cancer Cell International 2023 23:97
  31. Changes in Polyamine metabolism (PAM) have been shown to establish a suppressive tumor microenvironment (TME) and substantially influence the progression of cancer in the recent studies. However, newly emergin...

    Authors: Enkui Zhang, Chengsheng Ding, Shuchun Li, Batuer Aikemu, Xueliang Zhou, Xiaodong Fan, Jing Sun, Xiao Yang and Minhua Zheng
    Citation: Cancer Cell International 2023 23:96
  32. Emerging studies have shown that pyroptosis plays a non-negligible role in the development and treatment of tumors. However, the mechanism of pyroptosis in colorectal cancer (CRC) remains still unclear. Theref...

    Authors: Chengsheng Ding, Xiao Yang, Shuchun Li, Enkui Zhang, Xiaodong Fan, Ling Huang, Zirui He, Jing Sun, Junjun Ma, Lu Zang and Minhua Zheng
    Citation: Cancer Cell International 2023 23:95
  33. Our study and several studies have reported that in some cancers, including pancreatic ductal adenocarcinoma (PDAC), the expression of squamous lineage markers, such as esophagus-tissue-specific genes, correla...

    Authors: Kohei Yamakawa, Michiyo Koyanagi-Aoi, Akihito Machinaga, Nobuyuki Kakiuchi, Tomonori Hirano, Yuzo Kodama and Takashi Aoi
    Citation: Cancer Cell International 2023 23:94
  34. Colorectal tumor differentially expressed (CRNDE) is specifically expressed in human brains and is the most highly expressed lncRNA in gliomas. Nevertheless, its implications in low grade glioma (LGG) are stil...

    Authors: Chen Yang, Yingchuan Jiang, Fan Hu, Qiuping Li and Biao Qi
    Citation: Cancer Cell International 2023 23:93
  35. Rather low vaccination rates for Human papillomavirus (HPV) and pre-existing cervical cancer patients with limited therapeutic strategies ask for more precise prognostic model development. On the other side, t...

    Authors: Yuchong Yu, Yao Liu, Yuhong Li, Xiaoming Yang, Mi Han and Qiong Fan
    Citation: Cancer Cell International 2023 23:92

    The Correction to this article has been published in Cancer Cell International 2023 23:125

  36. Triple-Negative Breast Cancer (TNBC) is a lethal subtype of breast cancer with limited treatment options. The purpose of this Network Meta-Analysis (NMA) is to compare the efficacy and safety of inhibitors of ...

    Authors: Ibrahim Elmakaty, Ruba Abdo, Ahmed Elsabagh, Abdelrahman Elsayed and Mohammed Imad Malki
    Citation: Cancer Cell International 2023 23:90
  37. Cancer stem-like cells (CSCs) are a subpopulation of tumor cells responsible for tumor initiation, metastasis, chemoresistance, and relapse. Recently, CSCs have been identified in Uveal Melanoma (UM), which re...

    Authors: Alessandra Loda, Stefano Calza, Arianna Giacomini, Cosetta Ravelli, Adwaid Manu Krishna Chandran, Chiara Tobia, Giovanna Tabellini, Silvia Parolini, Francesco Semeraro, Roberto Ronca and Sara Rezzola
    Citation: Cancer Cell International 2023 23:89
  38. Although doxorubicin chemotherapy is commonly applied for treating different malignant tumors, cardiotoxicity induced by this chemotherapeutic agent restricts its clinical use. The use of silymarin/silibinin m...

    Authors: Mandeep Singh, Mustafa M. Kadhim, Abduladheem Turki Jalil, Shamam Kareem Oudah, Zafar Aminov, Fahad Alsaikhan, Zanko Hassan Jawhar, Andrés Alexis Ramírez-Coronel and Bagher Farhood
    Citation: Cancer Cell International 2023 23:88
  39. Tumor microenvironment and metabolic reprogramming are critical for tumor metastasis. Bone marrow-derived mesenchymal stem cells (BM-MSCs) are widely involved in the formation of tumor microenvironment and pre...

    Authors: Jiaying Huang, Xiang Wang, Jing Wen, Xinxin Zhao, Chen Wu, Lin Wang, Xiaoli Cao, Haibo Dong, Xuejing Xu, Feng Huang, Wei Zhu and Mei Wang
    Citation: Cancer Cell International 2023 23:87
  40. As a novel type of the prevalent post-transcriptional modifications, N7-methylguanosine (m7G) modification is essential in the tumorigenesis, progression, and invasion of many cancers, including bladder cancer...

    Authors: Lei Ren, Xu Yang, Jinwen Liu, Weifeng Wang, Zixiong Liu, Qingyuan Lin, Bin Huang, Jincheng Pan and Xiaopeng Mao
    Citation: Cancer Cell International 2023 23:85
  41. The clinical application of microRNAs in modern therapeutics holds great promise to uncover molecular limitations and conquer the unbeatable castle of cancer metastasis. miRNAs play a decisive role that regula...

    Authors: Muhammad Javed Iqbal, Zeeshan Javed, Haleema Sadia, Sajid Mehmood, Ali Akbar, Benish Zahid, Tariq Nadeem, Sadia Roshan, Elena Maria Varoni, Marcello Iriti, Eda Sönmez Gürer, Javad Sharifi-Rad and Daniela Calina
    Citation: Cancer Cell International 2023 23:84
  42. Reprogrammed metabolic network is a key hallmark of cancer. Profiling cancer metabolic alterations with spatial signatures not only provides clues for understanding cancer biochemical heterogeneity, but also h...

    Authors: Fukai Wang, Shuangshuang Ma, Panpan Chen, Yuhao Han, Zhaoyun Liu, Xinzhao Wang, Chenglong Sun and Zhiyong Yu
    Citation: Cancer Cell International 2023 23:83
  43. Hepatocellular carcinoma (HCC) is a malignancy worldwide with one of the worst prognoses. Emerging studies have revealed that long noncoding RNAs (lncRNAs) contribute to HCC progression. This research probes t...

    Authors: Jiang Huang, Yunfang Yang, Fulan Zhao, Zhuo Zhang, Jian Deng, Wei Lu and Xian Jiang
    Citation: Cancer Cell International 2023 23:82
  44. As negative modulators of G-protein-coupled receptors (GPCRs) signaling, regulators of G protein signaling (RGS) proteins facilitate various downstream cellular signalings through regulating kinds of heterotri...

    Authors: Lin Li, Qiang Xu and Chao Tang
    Citation: Cancer Cell International 2023 23:81

Annual Journal Metrics

  • 2022 Citation Impact
    5.8 - 2-year Impact Factor
    5.6 - 5-year Impact Factor
    0.994 - SNIP (Source Normalized Impact per Paper)
    1.145 - SJR (SCImago Journal Rank)

    2023 Speed
    34 days submission to first editorial decision for all manuscripts (Median)
    110 days submission to accept (Median)

    2023 Usage 
    2,067,719 downloads
    1,052 Altmetric mentions 

Institutional membership

Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).

Funding your APC

​​​​​​​Open access funding and policy support by SpringerOpen​​

​​​​We offer a free open access support service to make it easier for you to discover and apply for article-processing charge (APC) funding. Learn more here